Skip to Main Content

Hello, everyone, and how are you this morning? We are doing just fine, thank you, despite a bit of freezing rain that made for a challenging trip to the local schoolhouse, where we deposited the short person for another day of learning. Naturally, such adventures call for cups of stimulation. We are once again favoring maple pecan. As always, feel free to join us. Remember, no prescription is required, which means we do not demand rebates. Meanwhile, here are your tidbits. Hope you have a smashing day and do remember us when saucy developments arise.

The Sackler family withdrew more than $10 billion from Purdue Pharma from 2008 t0 2017, the New York Times writes, citing an audit filed in U.S. bankruptcy court. The money, which was distributed among trusts and overseas holdings companies, is more than eight times what the family took from Purdue in the 13 years after OxyContin was approved in 1995. The audit is likely to renew questions about how much the Sacklers should pay to resolve some 2,800 lawsuits that seek to hold Purdue accountable for the opioid crisis (click on #654).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!